Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 34 (6) , 804-808
- https://doi.org/10.1038/ki.1988.253
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Bone histologic response to deferoxamine in aluminum–related bone diseaseKidney International, 1987
- Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelationKidney International, 1987
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Elevated Bone Aluminum Content in Dialysis Patients Without OsteomalaciaMayo Clinic Proceedings, 1985
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- Successful Treatment of Dialysis Osteomalacia and Dementia, Using Desferrioxamine Infusions and Oral 1-Alpha HydroxycholecalciferolAmerican Journal of Nephrology, 1984
- EFFECT OF DESFERRIOXAMINE ON REMOVAL OF ALUMINIUM AND IRON BY COATED CHARCOAL HAEMOPERFUSION AND HAEMODIALYSISThe Lancet, 1983
- OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINEThe Lancet, 1983
- Aluminum removal by hemodialysisKidney International, 1981
- FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY: An Epidemiological SurveyPublished by Elsevier ,1979